Clinical Trial

Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma

Name: Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma — clinical trial record (NCT07602049)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The main purpose of this trial is to investigate and evaluate the efficacy of cryoablation combined with camrelizumab treatment to patients with advanced or inoperable soft tissue sarcomas after standard treatment failure.

Trial Details

NCT Number	NCT07602049
Lead Sponsor	Sun Yat-sen University
Conditions	Soft Tissue Sarcoma (STS), Osteosarcoma
Enrollment	57 participants
Start Date	2024-11-20
Primary Completion	2026-11-30 (estimated)
Study Completion	2027-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-22